We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.51%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.7B
AUM Growth
-$514M
(-1.2%)
Cap. Flow
-$612M
Cap. Flow
% of AUM
-1.5%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
2,385
New
223
Increased
794
Reduced
1,083
Closed
195
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$348M |
| 2 |
LyondellBasell Industries
LYB
|
+$251M |
| 3 |
Pfizer
PFE
|
+$244M |
| 4 |
Fidelity National Information Services
FIS
|
+$179M |
| 5 |
Amcor
AMCR
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$427M |
| 2 |
Kimberly-Clark
KMB
|
+$279M |
| 3 |
Procter & Gamble
PG
|
+$253M |
| 4 |
WP
Worldpay, Inc.
WP
|
+$194M |
| 5 |
General Mills
GIS
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.2% |
| 2 | Technology | 14.96% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Communication Services | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Cummins
CMI
$72.6B
| $9.22M | 0.02% |
56,697
-383,624
| -87% | -$61.4M |
|
602
Lennox International
LII
$12.5B
| $9.17M | 0.02% |
37,744
-114,765
| -75% | -$29.6M |
|
603
Puma Biotechnology
PBYI
$485M
| $9.12M | 0.02% |
847,590
+337,590
| +66% | +$3.65M |
|
604
Lazard
LAZ
$3.57B
| $9.02M | 0.02% |
257,576
+100,991
| +64% | +$3.58M |
|
605
Knight Transportation
KNX
$10.7B
| $9M | 0.02% |
248,010
+216,108
| +677% | +$7.51M |
|
606
East-West Bancorp
EWBC
$17.3B
| $8.95M | 0.02% |
202,024
-679,510
| -77% | -$29.9M |
|
|
CONE
607
DELISTED
CyrusOne Inc Common Stock
CONE
| $8.94M | 0.02% |
113,045
-1,930
| -2% | -$129K |
|
608
Healthpeak Properties
DOC
$14B
| $8.82M | 0.02% |
247,691
+181,554
| +275% | +$6.13M |
|
609
Unifirst Corp
UNF
$4.81B
| $8.81M | 0.02% |
45,128
+8,972
| +25% | +$1.74M |
|
|
ALXN
610
DELISTED
Alexion Pharmaceuticals
ALXN
| $8.75M | 0.02% |
89,313
+85,934
| +2,543% | +$9.69M |
|
611
NovoCure
NVCR
$1.89B
| $8.69M | 0.02% |
116,141
+114,773
| +8,390% | +$9.18M |
|
612
H.B. Fuller
FUL
$2.73B
| $8.65M | 0.02% |
185,697
+15,937
| +9% | +$728K |
|
613
iShares MSCI EAFE ETF
EFA
$77.6B
| $8.63M | 0.02% |
132,400
-36,500
| -22% | -$2.35M |
|
614
AeroVironment
AVAV
$7.95B
| $8.62M | 0.02% |
160,879
+124,832
| +346% | +$6.85M |
|
615
Orthofix Medical
OFIX
$363M
| $8.61M | 0.02% |
162,465
-6,616
| -4% | -$341K |
|
616
Ally Financial
ALLY
$12.3B
| $8.59M | 0.02% |
258,982
+182,845
| +240% | +$5.92M |
|
617
Medifast
MED
$134M
| $8.57M | 0.02% |
82,666
-45,734
| -36% | -$4.92M |
|
618
Middleby
MIDD
$5.08B
| $8.54M | 0.02% |
73,008
+6,321
| +9% | +$775K |
|
619
Jack in the Box
JACK
$253M
| $8.5M | 0.02% |
93,282
+83,452
| +849% | +$6.94M |
|
620
Ingevity
NGVT
$2.35B
| $8.49M | 0.02% |
100,053
-43,553
| -30% | -$3.88M |
|
621
Cintas
CTAS
$79.8B
| $8.44M | 0.02% |
125,948
+86,952
| +223% | +$5.57M |
|
|
TCDA
622
DELISTED
Tricida, Inc. Common Stock
TCDA
| $8.43M | 0.02% |
273,100
-1,493
| -0.5% | -$50K |
|
623
Aflac
AFL
$58.6B
| $8.37M | 0.02% |
160,024
-88,725
| -36% | -$4.68M |
|
624
Sempra
SRE
$53.4B
| $8.3M | 0.02% |
112,448
+2,756
| +3% | +$193K |
|
625
LXP Industrial Trust
LXP
$3.59B
| $8.27M | 0.02% |
161,334
-2,037
| -1% | -$102K |
|
Similar funds
Federated Hermes's Q3 2019 Portfolio in Review
As of Q3 2019, Federated Hermes held 2,385 positions worth $40.7B, down 1.2% from $41.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Federated Hermes's Q3 2019 filing shows 223 new, 794 increased, 1,083 reduced and 195 closed positions. Its largest new stake was Medallia, Inc.: 852,063 shares worth $23.4M. The largest sale was Crown Castle, an estimated $427M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q3 2019 buy was Medallia, Inc.: 852,063 shares worth $23.4M.
- Federated Hermes added most to Gilead Sciences in Q3 2019, an estimated $348M increase.
- Federated Hermes's biggest Q3 2019 reduction was Crown Castle, cutting an estimated $427M.
- Federated Hermes fully exited Worldpay, Inc. in Q3 2019, selling an estimated $194M.
- Federated Hermes's ten largest holdings make up 17% of its $40.7B portfolio in Q3 2019.
- Federated Hermes opened 223 new positions and closed 195 in Q3 2019.
- Federated Hermes's portfolio value fell 1.2% quarter-over-quarter to $40.7B.
Based on Federated Hermes's 13F filing for Q3 2019, filed 14 Nov 2019.